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Continuous infusion 
versus bolus injection of 
furosemide in critically ill 
patients.
A systematic review and 
meta-analysis
ABSTRACT
Introduction. Fluid overload and a positive fluid balance are common in the intensive care unit (ICU). Furosemide is frequently 
administered to increase  urine output. A bolus injection is the traditional mode of administration, but many concerns have been 
raised about possible intravascular volume fluctuations, toxicity and enhanced tolerance. Furosemide related adverse effects 
can be enhanced in critically ill patients. Continuous infusion should allow better hemodynamic stability, less side effects  and 
an easier achievement of the desired diuretic effect. We performed a systematic review and meta-analysis to compare the 
effects and complications of continuous furosemide infusion  with those of bolus injections in critically ill patients in the ICU. 
Methods. Studies were searched in PubMed (updated January 2009). Backward snowballing of included papers was per-
formed. International experts were contacted for further studies.
The inclusion criteria were: random allocation to treatment, comparison of furosemide bolus vs continuous infusion, per-
formed in surgical or intensive care patients. The exclusion criteria were: non-parallel design randomized trials, duplicate 
publications, non-human experimental studies, no outcome data.
Results. Four eligible randomized clinical trials were identified, including 129 patients (64 to continuous infusion and 65 to 
bolus treatment). Continuous perfusion was not associated with a significant reduction in risk of mortality as compared to 
bolus injection
Conclusions. Furosemide in continuous perfusion was not associated with a significant reduction in risk of hospital mortality 
as compared to bolus administration in critically ill patients in ICU, but existing data are insufficient to confidently assess 
the best way to administer  furosemide . Applying a protocol to drive furosemide therapy could be more relevant than the 
chosen mode of administration.
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Introduction
Fluid overload is a common problem 
in  critically ill patients of intensive care 
units (ICU); a positive fluid balance is 
often associated with a poor outcome. 
(1-4) Furosemide, a loop diuretic drug, is 
frequently administered to increase uri-
nary output. Intravenous bolus injection 
is the traditional mode of administration 
to obtain  prompt, vigorous diuresis. 
However, many concerns have been 
raised about possible marked intravas-
cular volume fluctuations, toxicity and 
enhanced tolerance. (5,6)
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Theoretically, continuous infusion of 
furosemide should allow better hemo-
dynamic stability and less side effects, 
together with an easier achievement 
of the desired diuretic effect. Studies 
comparing continuous infusion and 
bolus injection have been undertaken in 
healthy volunteers, patients with chronic 
renal failure, children after cardiac sur-
gery and patients with congestive heart 
failure (CHF). (7-10) A recent review of 
the 2 modes of administration in CHF 
patients concluded that “the existing 
data still does not allow definite recom-
mendations for clinical practice”. (11) 
Furosemide related adverse effects can 
be enhanced in critically ill patients: 
their labile circulatory system can be 
markedly affected by intravascular vol-
ume depletion; besides that, electro-
lyte imbalance must be avoided. As a 
matter of fact, diuretic administration 
in critically ill patients with acute renal 
failure (ARF) has been associated with 
an increased risk of death and non-
recovery of renal function. (12)
The aim of the present study was to 
compare effects and complications of 
continuous infusion of furosemide with 
those of bolus injections among criti-
cally ill patients in the ICU.
Materials and methods
Search Strategy P e r t i n e n t  s t u d -
ies were independently searched in 
PubMed (updated January 2009) by two 
trained investigators. The full PubMed 
search strategy, including the  key-
words furosemide, bolus, infusion and 
perfusion, was developed according to 
Biondi-Zoccai et al. (13) and is available 
in the appendix. In addition, we used 
backward snowballing (i.e. scanning 
of reference of retrieved articles and 
pertinent reviews) and we contacted 
international experts for further studies. 
No language restriction was enforced, 
and non-English-language articles were 
translated before further analysis.
Study Selection 
References obtained from database 
and literature searches were first inde-
pendently examined at the title/abstract 
level by two investigators, with diver-
gences resolved by consensus, and 
then, if potentially pertinent, retrieved 
as complete articles. The following 
inclusion criteria were employed for 
potentially relevant studies: a) random 
allocation to treatment, b) comparison 
of furosemide bolus vs continuous infu-
sion, c) performed in surgical or inten-
sive care patients. The exclusion criteria 
were: a) non-parallel design (i.e. cross-
over) randomized trials, b) duplicate 
publications, c) non-human experimen-
tal studies d) no outcome data. Two 
investigators selected studies for the 
final analysis by independently assess-
ing compliance with  selection criteria. 
Divergences from the selection criteria 
were resolved by consensus.
Data Abstraction and Study Character-
istics 
Baseline, procedural and outcome 
data were independently abstracted 
by two investigators, with divergences 
resolved by consensus. 
The primary end-point of our analysis 
was to determine whether a continu-
ous infusion of furosemide reduced 
hospital mortality as compared to bolus 
administration. 
Data Analysis and Synthesis 
Binary outcomes from individual stud-
ies were analyzed according to the 
Mantel-Haenszel model in order to 
compute individual odds ratios (OR) 
with pertinent 95% confidence intervals 
(CI), and a pooled summary effect esti-
mate was calculated by means of fixed 
effects model. (14) Statistical heteroge-
neity and inconsistency was measured 
using, respectively, Cochrane Q tests 
and I2. Statistical significance was set at 
the two-tailed 0.05 level for hypothesis 
testing and at the 0.10 for heterogene-
ity testing.  I2 values around 25%, 50% 
and 75% were considered representing 
respectively low, moderate and severe 
statistical inconsistency. Unadjusted P 
values are reported throughout. Com-
putations were performed with SPSS 
11.0 (SPSS, Chicago IL, USA) and Rev-
Man 4.2 (a freeware available from The 
Cochrane Collaboration). The study 
was performed in compliance with 
The Cochrane Collaboration and the 
Quality of Reporting of Meta-Analysis 
(QUOUM) guidelines.
Results
Database searches, snowballing and 
contacts with experts yielded a total of 
157 citations (figure 1). Excluding 148 
non-pertinent titles or abstracts, we 
retrieved nine studies in complete form 
and assessed them according to the 
selection criteria. A total of five studies 
were further excluded because of their 
non-experimental design, including the 
use of historical controls, or because of 
duplicate publications. We finally iden-
tified four eligible randomized clinical 
trials, (14-17) which were included in 
the final analysis 
Study Characteristics 
The four included RCTs (randomized 
controlled trials) randomized 129 
patients (64 to continuous infusion and 
65 to bolus treatment). All trials were 
performed on ICU patients. Three out 
of four authors tailored the drug dosage 
in an attempt to reach a pre-established 
urinary output in both groups. Patients 
were balanced as per age and baseline 
serum creatinine levels. Characteristics 
and results of the analyzed studies, 
and author’s conclusions, are report-
ed in table 1; patients’ characteristics 
are reported in table 2. Administered 
furosemide dosages, urine outputs, 
complications and length of stay in ICU 
in continuous and bolus groups are 
summarized in table 3.
Quantitative Data Synthesis 
Overall analysis showed that furosem-
ide in continuous perfusion was not 
associated with a significant reduction 
in the risk of mortality (6/55 [11.9%] in 
the continuous infusion group vs 10/56 
[17.8%] in the bolus arm, OR=0.60 
[0.20-1.84], p for effect=0.37, p for 
heterogeneity=0.91, I2=0%) (figure 
2). The studies appeared of subopti-
mal quality, as testified by the common 
lack of details on the method used for 
randomization sequence generation 
and allocation. No RCT employed a 
multicenter design, a feature that does 
not strictly impact on internal validity 
but usually increases external validity 
of a trial.
Discussion
Currently available data from four small 
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Figure 1. Flow-chart of the retrieved 
studies.
Figure 2. Forest plot of analyzed studies for risk of mortality. Overall analysis 
showed that furosemide in continuous perfusion was not associated with a 
significant reduction in the risk of mortality.
and relatively heterogeneous studies 
were insufficient to assess the merits of 
the two modes  of furosemide adminis-
tration in critically ill adult patients. Hos-
pital mortality does not appear to differ. 
Diuretic treatment is widely used in ICU 
to resolve fluid overload or to treat (or 
prevent) ARF; furosemide is by far the 
most commonly prescribed drug, at 
least for ARF patients. (18) In patients 
with acute lung injury, furosemide 
shortens mechanical ventilation and 
ICU stay, without ameliorating mortal-
ity. (19) In contrast, administration of 
loop diuretics in adult patients is not 
associated with clinical benefits in the 
treatment or prevention of ARF, as two 
Table 1. Characteristics and results of the analyzed studies, and author’s conclusions.
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recent reviews pointed out. (20-21) 
Mehta and co-workers showed that 
diuretic administrations in critically ill 
patients with ARF is associated with 
an increased risk of death and non-
recovery of renal function. (12) Other 
authors did not report higher mortality 
associated with diuretics. (18)
The best mode of furosemide adminis-
tration,  bolus injection vs.  continuous 
infusion, remains  to be demonstrated. 
Pharmacodynamic studies suggest 
that continuous infusion may be the 
most effective way to administer loop 
diuretics. (22) Loop diuretics act on 
the thick ascending loop of Henle, pro-
moting natriuresis and consequently 
diuresis. Their receptor is on the internal 
surface of the tubular lumen. The deliv-
ery time of loop diuretics to the action 
site within the lumen appears to deter-
mine the diuretic response more than 
the drug total dose or than its mode of 
administration. (23,24) The most effi-
cient drug excretion rate in terms of 
maximal sodium excretion (and diuretic 
response as well) can be determined 
(23) using continuous infusion- urinary 
furosemide excretion rate will be closer 
to the most efficient excretion rate over 
a longer period. (10) Other two mecha-
nisms could contribute to the superior 
efficacy of continuous infusion: acute 
drug tolerance is less pronounced, (6) 
and the drug-free interval during which 
sodium-retaining mechanisms act is 
shorter. (10) 
Continuous infusion of furosemide 
should have a better safety profile, 
allowing better hemodynamic stability 
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and less side effects, such as  ototox-
icity. (10)
Despite the wide use of furosemide and 
the fact that continuous infusion intui-
tively seems superior than bolus injec-
tion, we lack evidence on  this topic. 
Randomized controlled trials have 
focused on patients with congestive 
heart failure. A Cochrane review on the 
mode of administration of loop diuretics 
in this sub-group of patients found eight 
studies involving 254 patients. Studies 
were heterogeneous in terms of study 
population, dose, duration of the infu-
sion, presence or absence of a loading 
dose. Continuous infusion appeared to 


















Copeland JC (17) not reported not reported not reported not reported not reported not reported
Schuller D (16) 67 ± 15 67 + 15 1.9 + 1.10 2.3 + 2.30 14 + 5 15 + 7
Mojtahedzadeh 
M (15)
not reported not reported 1.8 + 0.15 1.5 + 0.19 mg/dl 18 ± 2.1 20 ± 1.5
Ostermann M 
(14)
60 ± 3.3 60 + 3.3 1.4 + 0.14 1.5 + 0.12 20 + 1.2 19 + 1.3
Table 3. Administered furosemide dosages, urine output, complications and length of stay (LOS) in intensive care unit 
(ICU) in continuous and bolus Groups.
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obtain greater diuresis, and to reduce 
mortality, hospital stay and ototoxicity; 
however, as the same authors stated, 
the poor quality of data could not allow 
robust recommendations for clinical 
practice. (11)
Very few controlled, randomised clinical 
trials have compared the two modes 
of administration in critically ill adult 
patients in the ICU setting. Martin pub-
lished an excellent review of the litera-
ture more than ten years ago, but a 
meta-analysis was never performed. 
(22) In ICU,  patients’ hemodynamic 
lability and latent ARF are balanced by 
intensive monitoring and rapid correc-
tion of imbalances, so it is difficult to 
predict if the differences between furo-
semide continuous infusion and bolus 
injection are minimized or emphasized 
in this setting. It should be noted that 
in critically ill adults the importance of 
applying a protocol to drive furosemide 
therapy appeared superior than the 
chosen mode of administration: Schull-
er (25) reported that a subgroup of non-
randomized (excluded for lacking of 
informed consent or unavailability of the 
research staff) patients in his study had 
less cumulative furosemide dose, less 
net diuresis, and longer ICU and hospi-
tal stay than randomized patients.
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Conclusions
Furosemide in continuous perfusion 
was not associated with a significant 
existing data are insufficient to confi-
dently assess the best way to adminis-
ter  furosemide . 
APPENDIX
Search strategy for PubMed, developed according to Biondi-Zoccai et al. (13)
(bolus AND (infus* OR perfusio*) AND (furosemide OR frusemide OR diuretic* OR diuresis)) AND (randomized controlled trial[pt] OR control-
led clinical trial[pt] OR randomized controlled trials[mh] OR random allocation[mh] OR double-blind method[mh] OR single-blind method[mh] 
OR clinical trial[pt] OR clinical trials[mh] OR (clinical trial[tw] OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] OR tripl*[tw]) AND (mask*[tw] OR 
blind[tw])) OR (latin square[tw]) OR placebos[mh] OR placebo*[tw] OR random*[tw] OR research design[mh:noexp] OR comparative study[tw] 
OR follow-up studies[mh] OR prospective studies[mh] OR cross-over studies[mh] OR control*[tw] OR prospectiv*[tw] OR volunteer*[tw]) NOT 
(animal[mh] NOT human[mh]) NOT (comment[pt] OR editorial[pt] OR meta-analysis[pt] OR practice-guideline[pt] OR review[pt]))
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